HeartBeam (HeartBeam) YoY EBITDA Growth : 64.36% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is HeartBeam YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. HeartBeam's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 64.36%.

HeartBeam's EBITDA per Share for the three months ended in Mar. 2024 was $-0.18.

HeartBeam YoY EBITDA Growth Historical Data

The historical data trend for HeartBeam's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeartBeam YoY EBITDA Growth Chart

HeartBeam Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

-168.42

-422.55

-199.25

52.79

HeartBeam Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial												-89.85	61.29	68.17	65.40	64.36

HeartBeam YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

HeartBeam's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-0.753	-	-1.595)	/	\| -1.595 \|
=	52.79 %

HeartBeam's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(-0.18	-	-0.505)	/	\| -0.505 \|
=	64.36 %

HeartBeam YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of HeartBeam's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

HeartBeam (HeartBeam) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » HeartBeam Inc (NAS:BEAT) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

2118 Walsh Avenue, Suite 210, Santa Clara, CA, USA, 95050

Website

https://www.heartbeam.com

HeartBeam Inc is a medical technology company primarily focusing on telemedicine solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. Its initial focus is providing diagnostic data to help physicians with the care management of patients with cardiovascular disease.

Executives

Urioste George De	director	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Kenneth Harry Persen	officer: Chief Technology Officer	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Robert Paul Eno	officer: President	2118 WALSH AVE, SUITE 210, SANTA CLARA CA 95050
Michael R Jaff	director	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Mark E Strome	10 percent owner	100 WILSHIRE BLVD, 15TH FL, SANTA MONICA CA 90401
Nelson Kenneth Warwick Iii	director	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Richard D Brounstein	officer: Chief Financial Officer	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Alan Baumel	officer: Chief Operating Officer	2118 WALSH AVE, SUITE 210, SANTA CLARA CA 94050
Marga Ortigas-wedekind	director	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Richard M Ferrari	director, officer: Exec Chm of the BOD	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Branislav Vajdic	10 percent owner, officer: Chief Executive Officer	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Willhem Elfrink	director	2118 WALSH AVE, SUITE 210, SANTA CLARA CA 95050
Jon Patrick Hunt	officer: Chief Business Officer	2118 WALSH AVE, SUITE 210, SANTA CLARA CA 95050